Team finds broken 'brake' on cancer mutation machine.

Published Date: 09 Aug 2023

According to a group led by UT Southwestern Medical, loss of the SYNCRIP gene in prostate cancer tumors unleashes cellular machinery that leads to random mutations throughout the genome that increase resistance to targeted therapies.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Admissions, medical schools, costs, and eligibility requirements information for FNB Head and Neck Oncology.

2.

Benefits of perioperative radiotherapy for liver cancer with a high risk of recurrence are investigated in research.

3.

Treating advanced prostate cancer

4.

Older Adults With Advanced Cancer Prioritize Quality of Life

5.

Nirogacestat is approved by the FDA for treating rare non-cancerous soft tissue sarcomas.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot